Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+171.6%
5Y CAGR+45.1%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+171.6%/yr
vs -50.5%/yr prior
5Y CAGR
+45.1%/yr
Recent acceleration
Acceleration
+222.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 838.09% |
| 2024 | -114.80% |
| 2023 | 8.96% |
| 2022 | 41.84% |
| 2021 | -13.63% |
| 2020 | 130.43% |
| 2019 | -43.88% |
| 2018 | 695.83% |
| 2017 | 335.14% |
| 2016 | 79.92% |